Inclusion Criteria:  Able to speak and read English Access to the internet Completed the Family Health History Tool (FHHT) through the Michigan Oncology Quality Consortium (MOQC).  Meeting clinical criteria for genetic evaluation due to any of the below:  Breast cancer either:  i. Diagnosed under 50 ii. PREMM risk model score ≥ 2.5% iii. Personal or family history of triple negative breast cancer iv. Ashkenazi Jewish ancestry v. Male proband vi. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer  Endometrial cancer either:  i. Diagnosed under 50 ii. PREMM risk model score ≥ 2.5%  Prostate cancer either:  i. Diagnosed under 50 ii. PREMM risk model score ≥ 2.5% iii. Ashkenazi Jewish ancestry iv. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer  Colorectal cancer either:  i. Diagnosed under 50 ii. PREMM risk model score ≥ 2.5% Ovarian cancer Pancreatic cancer  Exclusion Criteria:  Prior clinical germline genetic testing for cancer or already have an upcoming appointment scheduled with a genetics provider